A1344 - Milk fat globule membrane enriched whey protein concentrate for use as a nutritive substance in formulated supplementary foods for young children

This application seeks to permit milk fat globule membrane enriched whey protein concentrate for use as an optional nutritive substance in formulated supplementary foods for young children.

Consultation and assessment

Call for submissions

This application is being assessed under FSANZ’s general procedure and will include one round of public consultation. The current call for submissions will run from 9 July to 6 August 2026.

• A1344 Call for submissions (580 KB)
• A1344 Supporting document (503 KB)
• A1344 Application (2 MB)

Submissions can be made on the A1344 Consultation Hub page

Administrative Assessment

• A1344 Administrative Assessment Report (143KB)
• A1344 Executive Summary (92KB)